Expertise in Carbon Fixation Pathways
We specialize in engineering autotrophic metabolism (Calvin cycle, Wood-Ljungdahl pathway), which is the most critical step for converting gas into biomass.
Air protein, or Single Cell Protein ( SCP), represents a breakthrough in sustainable food production, converting gaseous carbon sources ( CO2, CH4) and nitrogen into high-quality protein biomass. Key challenges in commercialization include the low utilization rate of gas substrates , slow growth kinetics of the host bacteria, and insufficient final protein purity required for human consumption.
CD Biosynsis focuses on enhancing the efficiency of the core metabolic process: carbon fixation. We employ precise modification of microbial chassis carbon metabolism pathways and genetic strategies to enhance CO2 fixation via the Calvin cycle (or equivalent pathways). Our goal is to achieve a significant increase in growth rate and biomass yield while minimizing non-protein byproducts. We provide high-performance, food-grade engineered strains to accelerate the industrialization of sustainable, future-ready food sources.
Get a QuoteThe transition to large-scale, cost-effective air protein production faces several critical biological limitations:
Overcoming these challenges requires metabolic reprogramming to prioritize carbon fixation and protein synthesis.
CD Biosynsis applies advanced synthetic biology and metabolic engineering to enhance the efficiency of gas substrate conversion into high-quality protein:
Enhanced CO2 Fixation via the Calvin Cycle
We enhance the core carbon fixation pathway by overexpressing and optimizing the key enzyme RuBisCO and the associated regeneration enzymes, maximizing CO2 uptake and conversion efficiency.
Modification of Carbon Metabolism Pathways
The microbial chassis's central carbon metabolism is reprogrammed to prioritize flux towards amino acid synthesis pathways (the building blocks of protein), ensuring efficient conversion of fixed carbon to final product.
Growth Rate and H2 Utilization Optimization
We modify genes related to substrate transport and energy metabolism (e.g., hydrogenases in hydrogenotrophic bacteria) to improve bacterial growth kinetics, shortening the fermentation cycle and boosting overall productivity.
Protein Purity and Quality Enhancement
Genetic knockout strategies are employed to reduce the synthesis of undesirable components (e.g., non-protein RNA/DNA), significantly improving the final protein purity and nutritional profile for food applications.
This multi-target engineering ensures a significant leap in microbial performance, making SCP production both efficient and economically viable.
Choosing CD Biosynsis's Air Protein strain engineering service offers the following core value:
Expertise in Carbon Fixation Pathways
We specialize in engineering autotrophic metabolism (Calvin cycle, Wood-Ljungdahl pathway), which is the most critical step for converting gas into biomass.
Maximized Substrate Utilization
Our engineered strains show a significantly higher gas substrate utilization rate , directly reducing raw material costs and increasing process sustainability.
Food Grade Quality Focus
We prioritize genetic strategies that minimize contaminants, ensuring the final protein meets the highest purity and safety standards required for future food ingredients.
Accelerated Growth Kinetics
Engineering efforts shorten the fermentation cycle, leading to faster biomass accumulation and reduced overall operational expenditure.
Scalable and Sustainable Design
The engineered chassis is designed for robust performance in industrial bioreactors, providing a reliable and environmentally friendly protein source.
We are dedicated to providing genetically superior microbial strains to drive the commercial success of the air protein industry.
CD Biosynsis's Air Protein strain engineering service follows a standardized research workflow, ensuring every step is precise and controllable:
Technical communication is maintained throughout the process, focusing on timely performance feedback and strategic adjustments to the metabolic engineering plan.
Accelerate your Air Protein R&D and scale-up! CD Biosynsis provides customized SCP strain engineering solutions:
How does enhancing the Calvin cycle increase air protein yield?
The Calvin cycle is the core CO2 assimilation pathway. By optimizing and overexpressing the rate-limiting enzyme RuBisCO, we ensure that captured CO2 is rapidly and efficiently converted into three-carbon sugars, which are then channeled into biomass (protein) production, boosting the overall yield.
What are the key safety considerations for food-grade engineered strains?
Safety is paramount. We focus on non-pathogenic, generally recognized as safe ( GRAS) microbial hosts. Our engineering strategies avoid the introduction of antibiotic resistance markers and focus on chromosomal integration to ensure genetic stability and compliance with food regulatory standards.
What kind of gaseous substrates can be used?
Our solutions can be tailored for various gas-fed hosts, including those utilizing hydrogen ( H2) and carbon dioxide ( CO2) (hydrogenotrophic bacteria), or methane ( CH4) (methanotrophs), depending on the client's preferred energy source.
How do you improve the final protein purity?
A major impurity is nucleic acid. We use genetic strategies to reduce RNA/DNA accumulation and simultaneously enhance protein synthesis, ensuring the final biomass has a higher percentage of the desired protein for consumption.
What is the estimated project timeline?
Due to the complexity of autotrophic metabolism engineering, a complete project, including FBA, pathway editing, and validation under gaseous fermentation, typically requires 16-20 weeks .
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.